List of Studies ( Metabolite:Imidazolone)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004190 | AN006961 | Comparative Analysis of the Metabolic Profiles of Alix−/− and Ozz−/− Soleus Skeletal Muscle | Muscle | Mouse | St Jude Children's Research Hospital | LC-MS | |
| ST004190 | AN006962 | Comparative Analysis of the Metabolic Profiles of Alix−/− and Ozz−/− Soleus Skeletal Muscle | Muscle | Mouse | St Jude Children's Research Hospital | LC-MS | |
| ST003126 | AN005125 | Effect of high fat diet on heart metabolome of CHCHD10 mutant mice | Heart | Mouse | Cardiomyopathy | Weill Cornell Medicine | LC-MS |
| ST002998 | AN004925 | The role of gut microbiota in muscle mitochondria function, colon health, and sarcopenia: from clinical to bench | Bacterial cells | Faecalibacterium prausnitzii | Sarcopenia | Chinese University of Hong Kong | GC-MS/LC-MS |
| ST002998 | AN004925 | The role of gut microbiota in muscle mitochondria function, colon health, and sarcopenia: from clinical to bench | Bacterial cells | Lacticaseibacillus rhamnosus | Sarcopenia | Chinese University of Hong Kong | GC-MS/LC-MS |
| ST002094 | AN003422 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | LC-MS |
| ST000422 | AN000668 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000421 | AN000664 | ms3076 T1D poor glycemic control and control samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000047 | AN000082 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | LC-MS |
| ST000047 | AN000083 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | LC-MS |
| ST000046 | AN000079 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | LC-MS |
